THE COLOR OF ERGOMETRINE INJECTION - HOW TO RECOGNIZE LOW-LEVEL OF ACTIVE INGREDIENT

被引:3
作者
HOGERZEIL, HV
WALKER, GJA
VANDELANGERIJT, AEEM
机构
[1] WHO, Action Programme on Essential Drugs
[2] WHO, Maternal Health and Safe Motherhood Research
[3] Royal Dutch Association for the Advancement of Pharmacy, 2500 GL The Hague, Alexanderstraat I J
关键词
D O I
10.1177/004947559402400305
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:112 / 114
页数:3
相关论文
共 12 条
[1]  
Greenwood A.M., Greenwood B.M., Bradley A.K., A prospective survey of the outcome of pregnancy in a rural area of Gambia, Bull WHO, 65, pp. 635-643, (1987)
[2]  
Walker G.J.A., Ashley D.E.C., Mc Caw A., Bernard C.W., Maternal mortality in Jamaica, Lancet, pp. 486-488, (1986)
[3]  
Schuitemaker N.W.E., Gravenhorst J.B., Van Geijn H.P., Dekker G.A., Van Dongen P.W.J., Maternal mortality and its prevention, Eur J Obstet Gynecol Reprod Biol, 42, pp. S 31-S 35, (1991)
[4]  
Prendiville W., Elbourne D., Chalmers I., The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials, Br J Obstet Gynaecol, 95, pp. 3-16, (1988)
[5]  
Prendiville W.J., Harding J.E., Elbourne D.R., Stirrat G.M., The Bristol third stage trial: active versus physiological management of third stage of labour, BMJ, 297, pp. 1295-1300, (1988)
[6]  
Walker G.J.A., Hogerzeil H.V., Hillgren U., Potency of ergometrine in tropical countries, Lancet, (1988)
[7]  
(1993)
[8]  
(1990)
[9]  
Van Dongen P.W.J., Van Roosmalen J., De Boer C.N., Van Rooij J., Oxytocics for the prevention of postpartum haemorrhages, Pharm Weekbl (Sci), 13, 6, pp. 238-243, (1991)
[10]  
Mc Donald S.J., Prendiville W.J., Blair E., Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour, BMJ, 307, pp. 1167-1171, (1993)